Gayatri Digambar: Silent Plaque Rupture – The Hidden Trigger Behind Acute MI
Gayatri Digambar, B.Pharm Finalist and Registered Pharmacist, shared a post on LinkedIn:
“Silent Plaque Rupture: The Hidden Trigger Behind Acute MI
Background
Many patients presenting with Acute Myocardial Infarction (AMI) may have experienced silent plaque rupture days or even weeks earlier without noticeable symptoms.
Key Insights from Hemostasis & Thrombosis Research
- Subclinical plaque rupture can initiate localized thrombus formation
- Platelet activation plays a critical role in early clot development
- Micro-thrombi may intermittently form and dissolve before a major cardiac event occurs
Clinical Implication
Early detection of vulnerable plaques and improved understanding of platelet-driven thrombosis could significantly help prevent catastrophic cardiovascular events.
Future Perspective
As research evolves, integrating advanced imaging, circulating biomarkers, and platelet function studies may enhance early risk stratification in patients at risk of AMI.
Discussion Point
What are your thoughts on identifying pre-rupture plaque instability before major thrombotic events occur?”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids